MCID: LRN003
MIFTS: 49

Learning Disability malady

Categories: Mental diseases

Aliases & Classifications for Learning Disability

Aliases & Descriptions for Learning Disability:

Name: Learning Disability 12 14
Learning Disorders 52 41 42 69
Learning Disabilities 51 29 69
Academic Skill Disorder 12
Learning Disorder 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8927
ICD10 33 F81.9
MeSH 42 D007859
NCIt 47 C89334

Summaries for Learning Disability

MedlinePlus : 41 learning disorders affect how a person understands, remembers and responds to new information. people with learning disorders may have problems listening or paying attention speaking reading or writing doing math although learning disorders occur in very young children, they are usually not recognized until the child reaches school age. about one-third of children who have learning disabilities also have adhd, which makes it hard to focus. evaluation and testing by a trained professional can help identify a learning disorder. the next step is special education, which involves helping your child in the areas where he or she needs the most help. sometimes tutors or speech or language therapists also work with the children. learning disorders do not go away, but strategies to work around them can make them less of a problem. nih: national institute of neurological disorders and stroke

MalaCards based summary : Learning Disability, also known as learning disorders, is related to personality disorder and autism spectrum disorder. An important gene associated with Learning Disability is CDH8 (Cadherin 8). The drugs Ethanol and Norepinephrine have been mentioned in the context of this disorder. Affiliated tissues include testes, brain and heart, and related phenotypes are behavior/neurological and nervous system

Disease Ontology : 12 A specific developmental disorder that involves difficulty in scholastic skills such as reading, writing, spelling, reasoning, recalling and/or organizing information resulting from the brain's inability to receive and process information.

NINDS : 51 Learning disabilities are disorders that affect the ability to understand or use spoken or written language, do mathematical calculations, coordinate movements, or direct attention. Although learning disabilities occur in very young children, the disorders are usually not recognized until the child reaches school age. Research shows that 8 to 10 percent of American children under 18 years of age have some type of learning disability.

Wikipedia : 71 Learning disability is a classification that includes several areas of functioning in which a person has... more...

Related Diseases for Learning Disability

Diseases related to Learning Disability via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 144)
id Related Disease Score Top Affiliating Genes
1 personality disorder 29.5 FMR1 MAPT MECP2
2 autism spectrum disorder 29.1 DCDC2 FMR1 KIAA0319 MECP2
3 epilepsy, x-linked, with variable learning disabilities and behavior disorders 12.3
4 sotos syndrome 1 11.4
5 fragile x syndrome 11.2
6 shprintzen omphalocele syndrome 11.1
7 dyslexia 11.0
8 turner syndrome 11.0
9 dyscalculia 11.0
10 intellectual disability 11.0
11 feingold syndrome 10.9
12 dysgraphia 10.9
13 glut1 deficiency syndrome 1 10.8
14 leukoencephalopathy with ataxia 10.8
15 myopathy with extrapyramidal signs 10.8
16 legius syndrome 10.8
17 xfe progeroid syndrome 10.8
18 robin sequence with cleft mandible and limb anomalies 10.8
19 perrault syndrome 3 10.8
20 velocardiofacial syndrome 10.8
21 osteopathia striata with cranial sclerosis 10.8
22 landau-kleffner syndrome 10.8
23 pierpont syndrome 10.8
24 shprintzen-goldberg syndrome 10.6
25 neural tube defects 10.6
26 3mc syndrome 2 10.6
27 carbamoylphosphate synthetase i deficiency 10.6
28 septooptic dysplasia 10.6
29 dandy-walker syndrome 10.6
30 microphthalmia, syndromic 3 10.6
31 3mc syndrome 1 10.6
32 silver-russell syndrome 10.6
33 coffin-siris syndrome 10.6
34 bone marrow failure syndrome 2 10.6
35 spastic paraplegia 45, autosomal recessive 10.6
36 mucolipidosis iii alpha/beta 10.6
37 feingold syndrome 2 10.6
38 retinal dystrophy, juvenile cataracts, and short stature syndrome 10.6
39 prader-willi syndrome 10.6
40 bloom syndrome 10.6
41 n-acetylglutamate synthase deficiency 10.6
42 chromosome 19q13.11 deletion syndrome 10.6
43 glutathione synthetase deficiency 10.6
44 pseudopseudohypoparathyroidism 10.6
45 adrenoleukodystrophy 10.6
46 urbach-wiethe disease 10.6
47 goldberg-shprintzen megacolon syndrome 10.6
48 centrotemporal epilepsy 10.6
49 chromosome 22q11.2 microduplication syndrome 10.6
50 neuropathy, ataxia, and retinitis pigmentosa 10.6

Graphical network of the top 20 diseases related to Learning Disability:



Diseases related to Learning Disability

Symptoms & Phenotypes for Learning Disability

MGI Mouse Phenotypes related to Learning Disability:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.65 CDH8 CNTF DCDC2 FMR1 MAPT MECP2
2 nervous system MP:0003631 9.36 PSAP PURA ZIC1 CDH8 CNTF DCDC2

Drugs & Therapeutics for Learning Disability

Drugs for Learning Disability (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1076)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 64-17-5 702
2
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-41-2 439260
3
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
4
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 50-02-2 5743
5
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2 23214-92-8 31703
6
Vigabatrin Approved Phase 4 68506-86-5, 60643-86-9 5665
7
Tiagabine Approved Phase 4 115103-54-3 60648
8
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 60142-96-3 3446
9
Lamotrigine Approved, Investigational Phase 4,Phase 1 84057-84-1 3878
10
Phenytoin Approved, Vet_approved Phase 4,Early Phase 1 57-41-0 1775
11
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
12
Levodopa Approved Phase 4,Phase 2 59-92-7 6047
13
Nicotine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 54-11-5 942 89594
14
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1 79902-63-9 54454
15
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1 7440-66-6 32051 23994
16
Daunorubicin Approved Phase 4 20830-81-3 30323
17
Vincristine Approved, Investigational Phase 4,Phase 2 2068-78-2, 57-22-7 5978
18
Etoposide Approved Phase 4,Phase 2 33419-42-0 36462
19
Idarubicin Approved Phase 4,Phase 1,Phase 2 58957-92-9 42890
20
Cytarabine Approved, Investigational Phase 4,Phase 2,Phase 1 147-94-4 6253
21
Teniposide Approved Phase 4 29767-20-2 34698
22
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
23
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
24
Phenobarbital Approved Phase 4 50-06-6 4763
25
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
26
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
27
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 21679-14-1, 75607-67-9 30751
28
Valproic Acid Approved, Investigational Phase 4,Phase 3,Phase 2 99-66-1 3121
29
Warfarin Approved Phase 4,Phase 2 81-81-2 6691 54678486
30
Memantine Approved, Investigational Phase 4,Phase 2,Phase 3 19982-08-2 4054
31
Orlistat Approved, Investigational Phase 4 96829-58-2 3034010
32
Bupropion Approved Phase 4,Phase 3,Phase 2 34841-39-9, 34911-55-2 444
33
Topiramate Approved Phase 4,Phase 2,Phase 1,Early Phase 1 97240-79-4 5284627
34
Guanfacine Approved, Investigational Phase 4,Phase 3 29110-47-2 3519
35
Methylphenidate Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 113-45-1 4158
36
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 1 76631-46-4, 113775-47-6 68602 5311068 56032
37
Fluoxetine Approved, Vet_approved Phase 4,Phase 3,Phase 2 54910-89-3 3386
38
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-24-8 5755
39
Zonisamide Approved, Investigational Phase 4,Phase 3 68291-97-4 5734
40
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
41
Letrozole Approved, Investigational Phase 4,Phase 3,Phase 2 112809-51-5 3902
42
Remifentanil Approved Phase 4 132875-61-7 60815
43
Amitriptyline Approved Phase 4,Phase 3 50-48-6 2160
44
Methamphetamine Approved, Illicit Phase 4,Phase 2,Phase 1 537-46-2 10836
45
Citalopram Approved Phase 4,Phase 2,Phase 3,Phase 1 59729-33-8 2771
46
Fluvoxamine Approved, Investigational Phase 4 54739-18-3 3404 5324346
47
Ketamine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 6740-88-1 3821
48
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 10118-90-8 5281021
49
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 2078-54-8 4943
50
Amantadine Approved Phase 4,Phase 3,Phase 2 768-94-5 2130

Interventional clinical trials:

(show top 50) (show all 5431)
id Name Status NCT ID Phase
1 Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study Unknown status NCT00956696 Phase 4
2 Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis Unknown status NCT02330679 Phase 4
3 Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia Unknown status NCT00111371 Phase 4
4 Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI Unknown status NCT01329601 Phase 4
5 Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment Unknown status NCT00306124 Phase 4
6 Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis Unknown status NCT02452437 Phase 4
7 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4
8 Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities Unknown status NCT01302210 Phase 4
9 Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder Unknown status NCT01460212 Phase 4
10 Rajavithi Health Promotion Project (Population Base Cohort) Unknown status NCT00368095 Phase 4
11 Effect of Deksmedetomidine and Remifentanil in Extubation Agitation Unknown status NCT02104297 Phase 4
12 Treatment Youth With Obsessive-Compulsive Disorder Unknown status NCT00708240 Phase 4
13 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4
14 Treatment of Alcohol Dependence and Comorbid Bipolar Disorder Unknown status NCT01015586 Phase 4
15 Organization Program of DiabEtes INsulIN ManaGement Unknown status NCT01338376 Phase 4
16 The Role of Opinion Leaders in Enhancing Evidence-based Care After Chronic Obstructive Pulmonary Disease (COPD) Emergency Department (ED) Visits Unknown status NCT01107613 Phase 4
17 Assessment of Intellectual, Psychological and Behavioural Developments Between 6 and 9 Years of the Children Born to Hyperthyroid Mothers During Their Pregnancy Unknown status NCT01779817 Phase 4
18 Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity Unknown status NCT00878592 Phase 4
19 Pilonidal Disease Wound Healing Study Unknown status NCT01857128 Phase 4
20 Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents Unknown status NCT00252278 Phase 4
21 Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder Unknown status NCT01130467 Phase 4
22 Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients Unknown status NCT00871845 Phase 4
23 Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission Unknown status NCT01901666 Phase 4
24 Multidisciplinary Approach Versus Conventional Approach in Colonic Preparation of Hospitalized Patients Unknown status NCT01853709 Phase 4
25 Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder Unknown status NCT02048241 Phase 4
26 Revascularization in Heart Failure Trial – REHEAT 2 Unknown status NCT00388245 Phase 4
27 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) Unknown status NCT00198991 Phase 4
28 Healthy Opportunities for Physical Activity and Nutrition (HOP'N) After-School Project Unknown status NCT01015599 Phase 4
29 Methylphenidate in Healthy Young Adults Unknown status NCT00815841 Phase 4
30 Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy Unknown status NCT00552526 Phase 4
31 Eyegaze Systems for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943656 Phase 4
32 Amantadine for Treatment of Symptoms of the Post-Traumatic Confusional State Unknown status NCT00693121 Phase 4
33 Influence of Preoperative Enema Application on Return of Gastrointestinal Function After Elective Cesarean Section: A Randomized Controlled Study Approved for marketing NCT01917396 Phase 4
34 Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine Completed NCT01146002 Phase 4
35 An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD) Completed NCT01060150 Phase 4
36 Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) Completed NCT00191906 Phase 4
37 Interventions for Children With Attention and Reading Disorders Completed NCT01133847 Phase 4
38 Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia Completed NCT00607919 Phase 4
39 Effects of Atomoxetine on Brain Activation During Attention and Reading Tasks in Patients With ADHD & Comorbid Dyslexia Completed NCT00716274 Phase 4
40 Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD Completed NCT00191048 Phase 4
41 Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects Completed NCT01033851 Phase 4
42 Adaptive Support Ventilation in the Weaning of COPD Completed NCT00969605 Phase 4
43 Memantine and Cognitive Dysfunction in Bipolar Disorder Completed NCT00586066 Phase 4
44 Chronic Kidney Disease Prevention of An-Lo District, Keelung Completed NCT00644046 Phase 4
45 Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy Completed NCT01405027 Phase 4
46 Primary Care Intervention Strategy for Anxiety Disorders Completed NCT00347269 Phase 4
47 Feedback Reports and e-Learning in Primary Care Spirometry Completed NCT00962455 Phase 4
48 Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis Completed NCT02644499 Phase 4
49 Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder Completed NCT01831622 Phase 4
50 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder Completed NCT00203528 Phase 4

Search NIH Clinical Center for Learning Disability

Cochrane evidence based reviews: learning disorders

Genetic Tests for Learning Disability

Genetic tests related to Learning Disability:

id Genetic test Affiliating Genes
1 Learning Disabilities 29

Anatomical Context for Learning Disability

MalaCards organs/tissues related to Learning Disability:

39
Testes, Brain, Heart, Breast, Bone, Eye, Amygdala

Publications for Learning Disability

Articles related to Learning Disability:

(show top 50) (show all 619)
id Title Authors Year
1
Learning Disability Nursing in Secure Settings: working with complexity. ( 28052517 )
2017
2
C. F. Goodey, Learning Disability and Inclusion Phobia: Past, Present, Future (Oxon, and New York: Routledge, 2016), pp. viii, 178, AL79.00, hardback, AL25.49 kindle, ISBN: 978-0-415-82200-8 (hbk) and 978-0-203-55665-8 (ebk). ( 27998342 )
2017
3
Reading Comprehension Assessment through Retelling: Performance Profiles of Children with Dyslexia and Language-Based Learning Disability. ( 27313551 )
2016
4
Learning disability registers in primary care. ( 27364662 )
2016
5
Measurement of adherence in a randomised controlled trial of a complex intervention: supported self-management for adults with learning disability and type 2 diabetes. ( 27716063 )
2016
6
Resilience and Stress in Children and Adolescents with Specific Learning Disability. ( 27047553 )
2016
7
Nurses' perceptions of personal attributes required when working with people with a learning disability and an offending background: a qualitative study. ( 27439391 )
2016
8
Neonatal Sevoflurane Exposure Induces Adulthood Fear-induced Learning Disability and Decreases Glutamatergic Neurons in the Basolateral Amygdala. ( 27820300 )
2016
9
Patient- and carer-held health records: can they improve annual health checks for patients with learning disability? ( 27033499 )
2016
10
Learning Disability Nursing Award. ( 27154131 )
2016
11
What a patient with a learning disability would like you to know. ( 27707693 )
2016
12
An audit of the quality of inpatient care for adults with learning disability in the UK. ( 27091821 )
2016
13
Learning Disability Identification Consistency: The Impact of Methodology and Student Evaluation Data. ( 27428446 )
2016
14
Exploring the prevalence of learning disabilities in children with cutaneous mastocytosis: A pilot cohort study. ( 27846948 )
2016
15
"Be proud of the UKS advances in learning disability care". ( 27145650 )
2016
16
New leadership model for learning disability nursing. ( 27380709 )
2016
17
Health-Related Quality of Life for Children and Adolescents with Specific Language Impairment: A Cohort Study by a Learning Disabilities Reference Center. ( 27851795 )
2016
18
The Interaction of Learning Disability Status and Student Demographic Characteristics on Mathematics Growth. ( 26746313 )
2016
19
Homozygous FIBP nonsense variant responsible of syndromic overgrowth, with overgrowth, macrocephaly, retinal coloboma and learning disabilities. ( 26660953 )
2016
20
Deleterious mutation in GPR88 is associated with chorea, speech delay, and learning disabilities. ( 27123486 )
2016
21
Changes in Synaptic Transmission and Long-term Potentiation Induction as a Possible Mechanism for Learning Disability in an Animal Model of Multiple Sclerosis. ( 27032554 )
2016
22
Pitch perception deficits in nonverbal learning disability. ( 27710893 )
2016
23
Learning disability patients 'let down'. ( 26907112 )
2016
24
Definition of a Visuospatial Dimension as a Step Forward in the Diagnostic Puzzle of Nonverbal Learning Disability. ( 26986198 )
2016
25
An Independent Investigation of the Utility of the Learning Disability Screening Questionnaire (LDSQ) within a Community Learning Disability Team. ( 27990765 )
2016
26
Does language learning disability in school-age children affect semantic word learning when reading? ( 25615548 )
2015
27
MRI in assessing children with learning disability, focal findings, and reduced automaticity. ( 26180142 )
2015
28
State Learning Disability Eligibility Criteria: A Comprehensive Review. ( 25581001 )
2015
29
The experiences of orthopaedic and trauma nurses who have cared for adults with a learning disability. ( 26573892 )
2015
30
An evaluation of a Singing for the Brain pilot with people with a learning disability and memory problems or a dementia. ( 26160277 )
2015
31
Learning disability community nursing team. ( 26559109 )
2015
32
Auditory interference control in children with learning disability: An exploratory study. ( 26432540 )
2015
33
Gain-of-Function Mutations in ZIC1 Are Associated with Coronal Craniosynostosis and Learning Disability. ( 26340333 )
2015
34
Biological correlates of attention deficit hyperactivity disorder and specific learning disability, following stroke in a young child. ( 27212833 )
2015
35
"Learning disability nursing is still genuine nursing". ( 26492661 )
2015
36
Validating the Learning Disability Screening Questionnaire Against the Weschler Adult Intelligence Scale, Fourth Edition. ( 26214559 )
2015
37
'Recognized, Valued and Supported'? The Experiences of Adult Siblings of People with Autism Plus Learning Disability. ( 25753367 )
2015
38
Focal MRI and Learning Disability with Reduced Automaticity. ( 26933605 )
2015
39
Pro Re Nata (PRN) prescription in an Inpatient Low Secure Learning Disability Unit. ( 26417820 )
2015
40
Stable measures of number sense accuracy in math learning disability: Is it time to proceed from basic science to clinical application? ( 26459122 )
2015
41
Supported self-management for adults with type 2 diabetes and a learning disability (OK-Diabetes): study protocol for a randomised controlled feasibility trial. ( 26253237 )
2015
42
Win: Learning Disability Nursing. ( 25736671 )
2015
43
Research teaching in learning disability nursing: Exploring the views of student and registered learning disability nurses. ( 26008687 )
2015
44
A literature review exploring the preparation of mental health nurses for working with people with learning disability and mental illness. ( 25662482 )
2015
45
NHS strategy for learning disability. ( 26243087 )
2015
46
An analysis of differential item functioning by gender in the Learning Disability Screening Questionnaire (LDSQ). ( 25677033 )
2015
47
Partnerships set to move learning disability patients to community. ( 26530552 )
2015
48
Need for a Comprehensive Sex and Relationship Education Programme for Adults with Learning Disability. ( 26417818 )
2015
49
Dialectical behaviour therapy in an inpatient unit for women with a learning disability: Service users' perspectives. ( 26514772 )
2015
50
Sensitivity to general and specific numerical features in typical achievers and children with mathematics learning disability. ( 25633228 )
2015

Variations for Learning Disability

ClinVar genetic disease variations for Learning Disability:

6
id Gene Variation Type Significance SNP ID Assembly Location
1 FIBP NM_198897.1(FIBP): c.673C> T (p.Gln225Ter) single nucleotide variant Pathogenic/Likely pathogenic rs786204849 GRCh38 Chromosome 11, 65885181: 65885181

Expression for Learning Disability

Search GEO for disease gene expression data for Learning Disability.

Pathways for Learning Disability

GO Terms for Learning Disability

Cellular components related to Learning Disability according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytoplasmic ribonucleoprotein granule GO:0036464 8.62 FMR1 MAPT

Biological processes related to Learning Disability according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 neuron migration GO:0001764 9.43 DCDC2 DNAAF4 KIAA0319
2 developmental process GO:0032502 9.32 COLEC11 NPAS3
3 nervous system development GO:0007399 9.17 CNTF DCDC2 DNAAF4 FMR1 KIAA0319 PURA
4 complement activation, lectin pathway GO:0001867 9.16 COLEC11 MASP1
5 astrocyte activation GO:0048143 8.96 CNTF MAPT

Molecular functions related to Learning Disability according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 siRNA binding GO:0035197 8.62 FMR1 MECP2

Sources for Learning Disability

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....